Search research articles
Contact Us
Filters
Showing results (111-120 of 172) with videos related to
Page
of 18
Sort By:
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
March 22, 2003
[Gene expression profiling in prostatic cancer]
T Ernst, M Hergenhahn, M Kenzelmann, et al.
Blood
|
October 19, 2020
RUNX1 germline variants in RUNX1-mutant AML: how frequent?
Martijn P T Ernst, François G Kavelaars, Bob Löwenberg, et al.
Psychiatry Research
|
March 10, 2000
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study
L Chang, C S Grob, T Ernst, et al.
Pediatrics
|
February 7, 2001
Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero
L M Smith, L Chang, M L Yonekura, et al.
Bone
|
April 26, 2020
The association between renal function and BMD response to bisphosphonate treatment: Real-world cohort study using linked national registers
Bo Abrahamsen, Martin T Ernst, Christopher D Smith, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 28, 2020
Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density
Alexander J Rodríguez, Martin T Ernst, Mads Nybo, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2013
Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases
Justin T Ernst, Michael Liu, Harmon Zuccola, et al.
Iscience
|
January 6, 2020
Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
Mike Broeders, Pablo Herrero-Hernandez, Martijn P T Ernst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies
D F Kisor, W Plunkett, J Kurtzberg, et al.
Alimentary Pharmacology & Therapeutics
|
January 1, 1990
Loss of acid suppression during dosing with H2-receptor antagonists
C Wilder-Smith, F Halter, T Ernst, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 172) with videos related to
Sort By:
Page
of 18
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie
|
March 22, 2003
[Gene expression profiling in prostatic cancer]
T Ernst, M Hergenhahn, M Kenzelmann, et al.
Blood
|
October 19, 2020
RUNX1 germline variants in RUNX1-mutant AML: how frequent?
Martijn P T Ernst, François G Kavelaars, Bob Löwenberg, et al.
Psychiatry Research
|
March 10, 2000
Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study
L Chang, C S Grob, T Ernst, et al.
Pediatrics
|
February 7, 2001
Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero
L M Smith, L Chang, M L Yonekura, et al.
Bone
|
April 26, 2020
The association between renal function and BMD response to bisphosphonate treatment: Real-world cohort study using linked national registers
Bo Abrahamsen, Martin T Ernst, Christopher D Smith, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 28, 2020
Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density
Alexander J Rodríguez, Martin T Ernst, Mads Nybo, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 17, 2013
Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases
Justin T Ernst, Michael Liu, Harmon Zuccola, et al.
Iscience
|
January 6, 2020
Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
Mike Broeders, Pablo Herrero-Hernandez, Martijn P T Ernst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Pharmacokinetics of nelarabine and 9-beta-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies
D F Kisor, W Plunkett, J Kurtzberg, et al.
Alimentary Pharmacology & Therapeutics
|
January 1, 1990
Loss of acid suppression during dosing with H2-receptor antagonists
C Wilder-Smith, F Halter, T Ernst, et al.
Page
of 18